Information Journal Paper
APA:
Copy. (2020). Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial. TRIALS, 21(1), 0-0. SID. https://sid.ir/paper/1095035/en
Vancouver:
Copy. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial. TRIALS[Internet]. 2020;21(1):0-0. Available from: https://sid.ir/paper/1095035/en
IEEE:
Copy, “Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial,” TRIALS, vol. 21, no. 1, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/1095035/en